Shanghai Fudan Microelectronics Group Company Limited - 1385.HK

1385.HK Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
1385.HK	4.6	9.3	-1.3	-15.8	18.3	34.5	-35.2	134.1	156.5	684.3
S&P 500	1.0	3.7	2.2	2.3	8.9	23.9	32.3	80.6	196.5	33856.2

Compare 1385.HK with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	1385.HK
name	Shanghai Fudan Microelectronics Group Company Limited
price	14.98
changes percentage	4.6089
change	0.66
day low	14.06
day high	15.26
year high	25.6
year low	8.7
market cap	25490724430
price avg 50	15.0492
price avg 200	12.89715
exchange	HKSE
volume	6129000
avg volume	6161069
open	14.06
previous close	14.32
eps	0.79
pe	18.96
earnings announcement	2025-03-28T12:00:00.000+0000
shares outstanding	1701650496
timestamp	2025-01-17 08:08:13

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 25.0%

Overall Quarterly Financial Health: 43.0%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
revenue	3536259422	3538908884	-0.07
gross profit	2038146916	2288637659	-10.94
gross profit ratio	0.58	0.65	-10.88
research and development expenses	1010597572	735419692	37.42
operating expenses	1286729863	1014819331	26.79
interest income	15285785	14813114	3.19
interest expense	27985971	4354699	542.66
ebitda	1023054171	1304506937	-21.58
ebitdaratio	0.29	0.41	-29.71
operating income	751417053	1121399582	-32.99
operating income ratio	0.21	0.32	-32.94
net income	719494375	1076843340	-33.18
net income ratio	0.2	0.3	-33.13
eps	0.87	1.37	-36.50

Overall Score of Annual Income Statement

0.25 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 3,536 million in 2023 from 3,539 million in 2022 representing a change of -0.07%. This indicates a sales shrinking, which is a negative sign for the company.

  Gross Profit: Gross Profit decreased to 2,038 million in 2023 from 2,289 million in 2022 representing a change of -10.94%. This indicates a sales profitability decline, which is a negative sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses decreased to 1,011 million in 2023 from 735 million in 2022 representing a change of 37.42%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  Operating Expenses: Operating Expenses increased to 1,287 million in 2023 from 1,015 million in 2022 representing a change of 26.79%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 1,023 million in 2023 from 1,305 million in 2022 representing a change of -21.58%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Earnings per Share (EPS): EPS increased to 0.87 in 2023 from 0.87 in 2022 representing a change of -36.5%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

• 📈 Positive Indicators

  Operating Income: Operating income increased to 751 million in 2023 from 1,121 million in 2022 representing a change of -32.99%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 719 million in 2023 from 1,077 million in 2022 representing a change of -33.18%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0000000000
revenue	901351396	892743914	0.96
gross profit	507757741	505718183	0.40
gross profit ratio	0.56	0.57	-0.56
research and development expenses	294999334	245299852	20.26
operating expenses	338192374	316808415	6.75
interest income	4241189	3908573	8.51
interest expense	10523157	10936529	-3.78
ebitda	179639724	215842575	-16.77
ebitdaratio	0.2	0.21	-6.46
operating income	169565366	174990664	-3.10
operating income ratio	0.19	0.2	-4.03
net income	186845205	161246753	15.88
net income ratio	0.21	0.18	14.77
eps	0.22	0.2	10.00

Overall Score of Quarterly Income Statement

0.62 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 901 million in 2024Q2 from 893 million in 2024Q1 representing a change of 0.96%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 508 million in 2024Q2 from 506 million in 2024Q1 representing a change of 0.4%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 295 million in 2024Q2 from 245 million in 2024Q1 representing a change of 20.26%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  Net Income: Net income increased to 187 million in 2024Q2 from 161 million in 2024Q1 representing a change of 15.88%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 0.22 in 2024Q2 from 0.22 in 2024Q1 representing a change of 10.0%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Operating Expenses: Operating Expenses increased to 338 million in 2024Q2 from 317 million in 2024Q1 representing a change of 6.75%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 180 million in 2024Q2 from 216 million in 2024Q1 representing a change of -16.77%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Operating Income: Operating income decreased to 170 million in 2024Q2 from 175 million in 2024Q1 representing a change of -3.1%. The decrease in operating income indicates worse operational performance and decreased profitability.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
total assets	8411350886	6110888054	37.65
total liabilities	2449649077	957718676	155.78
total equity	5961701808	5153169377	15.69
cash and cash equivalents	1003337496	1190828339	-15.74
short term investments	30213750	80167958	-62.31
long term investments	77984721	118931168	-34.43
total current assets	5937283670	4327100944	37.21
total non current assets	2474067215	1783787109	38.70
total current liabilities	1879321133	903876332	107.92
total non current liabilities	570327944	53842343	959.26
common stock	81906040	81665650	0.29
retained earnings	3381266932	2772141379	21.97
total debt	1517974753	102344090	1383.21

Overall Score of Annual Balance Sheet

0.5 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 8,411 million in 2023 from 6,111 million in 2022 representing a change of 37.65%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 5,962 million in 2023 from 5,153 million in 2022 representing a change of 15.69%. This indicates an increase in shareholders' equity.

  Total Current Assets: Total Current Assets increased to 5,937 million in 2023 from 4,327 million in 2022 representing a change of 37.21%. This indicates a better liquidity position.

  Common Stock: Common Stock increased to 82 in 2023 from 82 in 2022 representing a change of 0.29%. This indicates an increase in ownership interest.

  Retained Earnings: Retained Earnings increased to 3,381 million in 2023 from 2,772 million in 2022 representing a change of 21.97%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 2,450 million in 2023 from 958 million in 2022 representing a change of 155.78%. This indicates an increase in overall liabilities.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 1,003 million in 2023 from 1,191 million in 2022 representing a change of -15.74%. This indicates a decrease in available liquid assets.

  Short Term Investments: Short Term Investments decreased to 30 million in 2023 from 80 million in 2022 representing a change of -62.31%. This indicates a decrease in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities increased to 1,879 million in 2023 from 904 million in 2022 representing a change of 107.92%. This indicates a higher short-term debt burden.

  Total Debt: Total Debt increased to 1,518 million in 2023 from 102 million in 2022 representing a change of 1383.21%. This indicates an increase in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0000000000
total assets	8665834071	8495933812	2.00
total liabilities	2425161836	2360948827	2.72
total equity	6240672234	6134984985	1.72
cash and cash equivalents	813008807	770782536	5.48
short term investments	140423111	115256111	21.84
long term investments	76025776	76841671	-1.06
total current assets	6116690265	5896510626	3.73
total non current assets	2549143806	2599423185	-1.93
total current liabilities	2027254499	1855553774	9.25
total non current liabilities	397907336	505395052	-21.27
common stock	81906040	81906040	0.00
retained earnings	3647452851	3542513685	2.96
total debt	1540513058	1396665666	10.30

Overall Score of Quarterly Balance Sheet

0.67 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 8,666 million in 2024Q2 from 8,496 million in 2024Q1 representing a change of 2.0%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 6,241 million in 2024Q2 from 6,135 million in 2024Q1 representing a change of 1.72%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 813 million in 2024Q2 from 771 million in 2024Q1 representing a change of 5.48%. This indicates an increase in available liquid assets.

  Short Term Investments: Short Term Investments increased to 140 million in 2024Q2 from 115 million in 2024Q1 representing a change of 21.84%. This indicates an increase in short-term investment holdings.

  Total Current Assets: Total Current Assets increased to 6,117 million in 2024Q2 from 5,897 million in 2024Q1 representing a change of 3.73%. This indicates a better liquidity position.

  Retained Earnings: Retained Earnings increased to 3,647 million in 2024Q2 from 3,543 million in 2024Q1 representing a change of 2.96%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 2,425 million in 2024Q2 from 2,361 million in 2024Q1 representing a change of 2.72%. This indicates an increase in overall liabilities.

  Total Current Liabilities: Total Current Liabilities increased to 2,027 million in 2024Q2 from 1,856 million in 2024Q1 representing a change of 9.25%. This indicates a higher short-term debt burden.

  Total Debt: Total Debt increased to 1,541 million in 2024Q2 from 1,397 million in 2024Q1 representing a change of 10.3%. This indicates an increase in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
net change in cash	-127361949	704531639	-118.08
operating cash flow	-708166613.52	321285470	-320.42
free cash flow	-1559099877.74	-461241283.65	-238.02
capital expenditure	-850933264.22	-782526753.65	-8.74
depreciation and amortization	243217345	178641550	36.15
deferred income tax	0	-128429647.67	100.00
stock based compensation	106878728	128429649	-16.78
accounts payables	0	735797538	-100.00
inventory	-1814641268.79	-681591826.12	-166.24
acquisitions net	0	1.22	-100.00
investments in property plant and equipment	-850933264	-782526753.65	-8.74
net cash used for investing activites	-731596776	-132514506.43	-452.09
debt repayment	1426019350	-10588792	13567.25
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	-136932887	-55133885.75	-148.36
net cash used provided by financing activities	1310270707	504586861	159.67
cash at end of period	992924996	1120286945	-11.37
accounts receivables	-239195029	-735797538	67.49
cash at beginning of period	1120286945	415755306	169.46

Overall Score of Annual Cashflow Statement

None

Detailed Analysis

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0000000000
operating cash flow	116548565	10580615	1001.53
free cash flow	53633425	-122070275.15	143.94
capital expenditure	-62915139	-132650890.15	52.57
depreciation and amortization	153867602	0	NaN
deferred income tax	0	0	NaN
stock based compensation	31549427	0	NaN
accounts receivables	0	0	NaN
accounts payables	0	0	NaN
inventory	0	0	NaN
acquisitions net	0	0	NaN
investments in property plant and equipment	-62915139.18	-132650890.15	52.57
net cash used for investing activites	-88064159	-236550874.02	62.77
debt repayment	80978102	-5052696	1702.67
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	-72193707	-12407904.97	-481.84
net cash used provided by financing activities	16759462	-24290369.2	169.00
net change in cash	41762242	-252364876	116.55
cash at end of period	782322362	740560120	5.64
cash at beginning of period	740560120	992924996	-25.42

Overall Score of Quarterly Cashflow Statement

None

Detailed Analysis

Earnings Transcripts ⓘ

No earnings transcripts available.

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	4.33	4.34	-0.30
net income per share	0.88	1.32	-33.33
operating cash flow per share	-0.87	0.39	-319.93
free cash flow per share	-1.91	-0.57	-237.27
cash per share	1.26	1.56	-18.86
book value per share	7.29	6.32	15.43
tangible book value per share	6.56	5.82	12.62
shareholders equity per share	6.49	5.55	16.77
interest debt per share	1.89	0.13	1345.68
market cap	30742032374.4	56950328452.29	-46.02
enterprise value	31256669631.4	55861844203.29	-44.05
pe ratio	42.73	52.89	-19.21
price to sales ratio	8.69	16.09	-45.98
pocfratio	-43.41	177.26	-124.49
pfcf ratio	-19.72	-123.47	84.03
pb ratio	5.8	12.57	-53.88
ptb ratio	5.8	12.57	-53.88
ev to sales	8.84	15.79	-44.00
enterprise value over ebitda	30.05	42.82	-29.83
ev to operating cash flow	-44.14	173.87	-125.39
ev to free cash flow	-20.05	-121.11	83.45
earnings yield	0.02	0.02	23.78
free cash flow yield	-0.05	-0.01	-526.19
debt to equity	0.29	0.02	1167.35
debt to assets	0.18	0.02	977.56
net debt to ebitda	0.49	-0.83	159.29
current ratio	3.16	4.79	-34.01
interest coverage	26.85	257.51	-89.57
income quality	-0.98	0.29	-442.27
dividend yield	0.0	0.0	360.10
payout ratio	0.19	0.05	271.72
sales general and administrative to revenue	0.02	0.02	27.80
research and ddevelopement to revenue	0.29	0.21	37.52
intangibles to total assets	0.07	0.07	8.25
capex to operating cash flow	-1.2	2.44	-149.33
capex to revenue	0.24	0.22	8.82
capex to depreciation	3.5	4.38	-20.13
stock based compensation to revenue	0	0.04	-100.00
graham number	11.33	12.84	-11.77
roic	0.1	0.21	-52.86
return on tangible assets	0.09	0.19	-51.17
graham net net	1.57	2.27	-31.05
working capital	4057962537	3423224612	18.54
tangible asset value	5362316362	4750897048	12.87
net current asset value	3487634604	3369382268	3.51
invested capital	6311218656	4936059560	27.86
average receivables	1270639305.5	944061725.5	34.59
average payables	218469683.5	200722699	8.84
average inventory	2330317592	1199673806	94.25
days sales outstanding	152.47	109.75	38.93
days payables outstanding	57.44	58.73	-2.20
days of inventory on hand	774.13	433.02	78.78
receivables turnover	2.39	3.33	-28.02
payables turnover	6.35	6.21	2.25
inventory turnover	0.47	0.84	-44.06
roe	0.14	0.24	-42.91
capex per share	1.04	0.96	8.50

• ROE:

• Negative

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 42.73 on 2023-12-31 from 52.89 on 2022-12-31, representing a change of -19.21%. Indicating a decrease in the relative valuation of the company's stock.

  Current Ratio: Current Ratio decreased to 3.16 on 2023-12-31 from 4.79 on 2022-12-31, representing a change of -34.01%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.

• Neutral

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.29 on 2023-12-31 from 0.02 on 2022-12-31, representing a change of 1167.35%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Quarterly Financial Ratios

	2024-09-30 Q3	2024-06-30 Q2	Q/Q change %
1385.HK
calendar year	2024	2024	NaN
revenue per share	1.08	1.1	-1.30
net income per share	0.1	0.23	-57.64
operating cash flow per share	-0.02	0.14	-110.96
free cash flow per share	-0.07	0.07	-208.75
cash per share	1.24	1.16	6.36
book value per share	7.74	7.62	1.61
tangible book value per share	6.9	6.82	1.15
shareholders equity per share	6.97	6.84	1.93
interest debt per share	2.07	1.89	9.34
market cap	28961975744	25317156964	14.40
enterprise value	29923455415	26044661215	14.89
pe ratio	91.48	33.87	170.06
price to sales ratio	32.64	28.16	15.91
pocfratio	-2256.39	216.19	-1143.72
pfcf ratio	-491.43	467.17	-205.19
pb ratio	5.07	4.52	12.23
ptb ratio	5.07	4.52	12.23
ev to sales	33.72	28.97	16.41
enterprise value over ebitda	373.62	101.17	269.30
ev to operating cash flow	-2331.3	222.4	-1148.25
ev to free cash flow	-507.74	480.59	-205.65
earnings yield	0.0	0.01	-62.97
free cash flow yield	-0.0	0.0	-195.06
debt to equity	0.3	0.28	7.32
debt to assets	0.19	0.18	7.22
net debt to ebitda	12.0	2.83	324.81
current ratio	2.84	3.02	-5.82
interest coverage	3.77	9.64	-60.90
income quality	-0.16	0.63	-125.87
dividend yield	0.0	0.0	-0.82
payout ratio	1.03	0.39	167.83
sales general and administrative to revenue	0	-0.02	100.00
research and ddevelopement to revenue	0.3	0.29	2.68
intangibles to total assets	0.08	0.08	3.46
capex to operating cash flow	-3.59	0.54	-768.50
capex to revenue	0.05	0.07	-25.76
capex to depreciation	0	0.82	-100.00
stock based compensation to revenue	0	0.04	-100.00
graham number	3.89	5.92	-34.29
roic	0.01	0.01	-62.80
return on tangible assets	0.01	0.02	-58.37
graham net net	1.85	1.8	2.75
working capital	4072495575	4089435766	-0.41
tangible asset value	5652689548	5588691521	1.15
net current asset value	3783053360	3691528429	2.48
invested capital	6410322250	6432324861	-0.34
average receivables	1811950067	1700556057.5	6.55
average payables	262470588.5	275613943	-4.77
average inventory	3225798179	3222914502	0.09
days sales outstanding	187.94	177.29	6.01
days payables outstanding	52.55	57.22	-8.15
days of inventory on hand	680.74	669.03	1.75
receivables turnover	0.48	0.51	-5.67
payables turnover	1.71	1.57	8.88
inventory turnover	0.13	0.13	-1.72
roe	0.01	0.03	-58.44
capex per share	0.06	0.08	-26.73

• Negative

  ROE: Return on Equity (ROE) decreased to 0.01 on 2024-09-30 Q3 from 0.03 on 2024-06-30 Q2, representing a change of -58.44%. Suggesting that the company has not been generating high returns for its shareholders.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 91.48 on 2024-09-30 Q3 from 33.87 on 2024-06-30 Q2, representing a change of 170.06%. Indicating an increase in the relative valuation of the company's stock.

• Neutral

  Current Ratio: Current Ratio decreased to 2.84 on 2024-09-30 Q3 from 3.02 on 2024-06-30 Q2, representing a change of -5.82%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.30 on 2024-09-30 Q3 from 0.28 on 2024-06-30 Q2, representing a change of 7.32%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

None